- Home
- DCI vs ASND Comparison
DCI vs ASND Comparison
Compare DCI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCI | ASND |
|---|---|---|
| Founded | 1915 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 13.6B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DCI | ASND |
|---|---|---|
| Price | $85.83 | $219.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 16 |
| Target Price | $100.80 | ★ $279.50 |
| AVG Volume (30 Days) | ★ 687.7K | 598.9K |
| Earning Date | 02-26-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $2,844,900,000.00 | N/A |
| Revenue This Year | $4.58 | $98.57 |
| Revenue Next Year | $5.08 | $43.22 |
| P/E Ratio | $47.71 | ★ N/A |
| Revenue Growth | ★ 4.05 | N/A |
| 52 Week Low | $57.45 | $124.06 |
| 52 Week High | $112.84 | $248.60 |
Technical Indicators
Market Signals| Indicator | DCI | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 31.83 | 40.17 |
| Support Level | $83.32 | $189.53 |
| Resistance Level | $88.88 | $222.47 |
| Average True Range (ATR) | 1.92 | 7.05 |
| MACD | -0.34 | -2.23 |
| Stochastic Oscillator | 31.43 | 6.24 |
Price Performance
Historical ComparisonAbout DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.